argenx SE

$330.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$8.79 (-2.59%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell argenx SE and other stocks, options, and ETFs commission-free!

About ARGX

argenx SE American Depositary Shares, also called argenx SE, is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren on April 25, 2008 and is headquartered in Breda, the Netherlands. The listed name for ARGX is argenx SE American Depositary Shares.

CEO
Tim van Hauwermeiren
Employees
188
Headquarters
Breda, Noord-Brabant
Founded
2008
Market Cap
17.25B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
165.28K
High Today
$344.35
Low Today
$328.77
Open Price
$341.74
Volume
181.21K
52 Week High
$382.15
52 Week Low
$103.75

ARGX Earnings

-$3.96
-$2.64
-$1.32
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$3.20 per share
Actual
Available Mar 4, Pre-Market

You May Also Like

FACA=
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure